PSMA PET/CT vs. WBBS for Prostate Cancer Staging: A Comparison

What is it about?

This study compares the diagnostic performance and radiological staging impact of 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and 99 Tc whole-body bone scan (WBBS) for the detection of skeletal metastasis in the primary staging of prostate cancer (PCa). The study analyzed a large cohort of 667 patients who underwent both PSMA PET and WBBS within a 1-week interval for PCa primary staging. The results showed that PSMA PET/CT detected more metastatic disease than WBBS and was more likely to result in upward classification of stage and disease burden migration. The SUV max of the primary tumor was associated with upstaging with 68 Ga-PSMA PET/CT, likely related to a significant association with the burden of metastatic disease, while age was the only predictor associated with upstaging with WBBS. The study concluded that PSMA PET/CT is more accurate than WBBS in detecting skeletal metastasis in the primary staging of PCa, particularly in high-risk patients.

Featured Image

Why is it important?

This research is important because it compares the diagnostic performance and radiological staging impact of 68 Ga-prostate-specific membrane antigen positron emission tomography/computed tomography (PSMA PET/CT) and 99 Tc whole-body bone scan (WBBS) for the detection of skeletal metastasis in the primary staging of prostate cancer (PCa). This study provides valuable information for clinicians and patients in decision-making, as PSMA PET/CT detects more metastatic disease than WBBS and is more likely to result in upward classification of stage and disease burden migration. Key Takeaways: 1. PSMA PET/CT detected more skeletal metastases than WBBS, resulting in a higher upstaging rate, particularly in high-risk patients. 2. The SUV max of the primary tumour was associated with upstaging with 68 Ga-PSMA PET/CT, likely related to a significant association with the burden of metastatic disease, while age was the only predictor associated with upstaging with WBBS. 3. Stage migration, including both upstaging and downstaging, reflects the improved accuracy of PSMA PET/CT and will allow for better-informed decision-making for clinicians and patients. 4. The study provides real-world data in the setting of primary staging in patients of all risk groups, which is more reflective of how PSMA PET/CT performs in a community setting.